• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S28蛋白酶家族的结构定义与底物特异性:人脯氨酰羧肽酶的晶体结构

Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase.

作者信息

Soisson Stephen M, Patel Sangita B, Abeywickrema Pravien D, Byrne Noel J, Diehl Ronald E, Hall Dawn L, Ford Rachael E, Reid John C, Rickert Keith W, Shipman Jennifer M, Sharma Sujata, Lumb Kevin J

机构信息

Global Structural Biology, Merck Research Laboratories, P,O, Box 4, West Point, PA 19486, USA.

出版信息

BMC Struct Biol. 2010 Jun 11;10:16. doi: 10.1186/1472-6807-10-16.

DOI:10.1186/1472-6807-10-16
PMID:20540760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2893456/
Abstract

BACKGROUND

The unique S28 family of proteases is comprised of the carboxypeptidase PRCP and the aminopeptidase DPP7. The structural basis of the different substrate specificities of the two enzymes is not understood nor has the structure of the S28 fold been described.

RESULTS

The experimentally phased 2.8 A crystal structure is presented for human PRCP. PRCP contains an alpha/beta hydrolase domain harboring the catalytic Asp-His-Ser triad and a novel helical structural domain that caps the active site. Structural comparisons with prolylendopeptidase and DPP4 identify the S1 proline binding site of PRCP. A structure-based alignment with the previously undescribed structure of DPP7 illuminates the mechanism of orthogonal substrate specificity of PRCP and DPP7. PRCP has an extended active-site cleft that can accommodate proline substrates with multiple N-terminal residues. In contrast, the substrate binding groove of DPP7 is occluded by a short amino-acid insertion unique to DPP7 that creates a truncated active site selective for dipeptidyl proteolysis of N-terminal substrates.

CONCLUSION

The results define the structure of the S28 family of proteases, provide the structural basis of PRCP and DPP7 substrate specificity and enable the rational design of selective PRCP modulators.

摘要

背景

独特的S28蛋白酶家族由羧肽酶PRCP和氨肽酶DPP7组成。两种酶不同底物特异性的结构基础尚不清楚,S28折叠的结构也未被描述。

结果

给出了人PRCP的2.8埃晶体结构,该结构通过实验确定了相位。PRCP包含一个带有催化性天冬氨酸-组氨酸-丝氨酸三联体的α/β水解酶结构域和一个覆盖活性位点的新型螺旋结构域。与脯氨酰内肽酶和DPP4的结构比较确定了PRCP的S1脯氨酸结合位点。与之前未描述的DPP7结构进行基于结构的比对,阐明了PRCP和DPP7正交底物特异性的机制。PRCP具有一个延伸的活性位点裂隙,可容纳带有多个N端残基的脯氨酸底物。相比之下,DPP7的底物结合凹槽被DPP7特有的短氨基酸插入所封闭,从而形成了一个对N端底物的二肽基蛋白水解具有选择性的截短活性位点。

结论

这些结果确定了S28蛋白酶家族的结构,提供了PRCP和DPP7底物特异性的结构基础,并有助于合理设计选择性PRCP调节剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/a3633796370b/1472-6807-10-16-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/8339244aa943/1472-6807-10-16-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/2d8440d5be6c/1472-6807-10-16-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/70ddb09453fd/1472-6807-10-16-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/91989c8b9b5a/1472-6807-10-16-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/1d7dc954fe06/1472-6807-10-16-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/a67f78754aef/1472-6807-10-16-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/83e6492042ae/1472-6807-10-16-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/a3633796370b/1472-6807-10-16-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/8339244aa943/1472-6807-10-16-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/2d8440d5be6c/1472-6807-10-16-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/70ddb09453fd/1472-6807-10-16-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/91989c8b9b5a/1472-6807-10-16-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/1d7dc954fe06/1472-6807-10-16-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/a67f78754aef/1472-6807-10-16-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/83e6492042ae/1472-6807-10-16-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc8/2893456/a3633796370b/1472-6807-10-16-8.jpg

相似文献

1
Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase.S28蛋白酶家族的结构定义与底物特异性:人脯氨酰羧肽酶的晶体结构
BMC Struct Biol. 2010 Jun 11;10:16. doi: 10.1186/1472-6807-10-16.
2
Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.重组脯氨酰羧肽酶对激肽的高选择性水解。
Biochem Biophys Res Commun. 2011 Feb 18;405(3):338-43. doi: 10.1016/j.bbrc.2010.12.036. Epub 2010 Dec 16.
3
S28 peptidases: lessons from a seemingly 'dysfunctional' family of two.S28 肽酶:来自看似“功能失调”的双肽酶家族的启示。
BMC Biol. 2010 Jun 28;8:87. doi: 10.1186/1741-7007-8-87.
4
Structures of human DPP7 reveal the molecular basis of specific inhibition and the architectural diversity of proline-specific peptidases.人源 DPP7 结构揭示了其特异性抑制的分子基础和脯氨酰特异性肽酶的结构多样性。
PLoS One. 2012;7(8):e43019. doi: 10.1371/journal.pone.0043019. Epub 2012 Aug 29.
5
Crystal structure and substrate recognition mechanism of the prolyl endoprotease PEP from Aspergillus niger.黑曲霉脯氨酰内肽酶 PEP 的晶体结构与底物识别机制。
Biochem Biophys Res Commun. 2022 Feb 5;591:76-81. doi: 10.1016/j.bbrc.2021.12.114. Epub 2022 Jan 1.
6
Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase.人类脑脊液的肽组学分析鉴定出 YPRPIHPA 是脯氨酰羧肽酶的一种新型底物。
Proteomics. 2010 Aug;10(15):2882-6. doi: 10.1002/pmic.201000145.
7
Crystal structure of mutant carboxypeptidase T from Thermoactinomyces vulgaris with an implanted S1' subsite from pancreatic carboxypeptidase B.来自嗜热放线菌的突变羧肽酶T的晶体结构,其植入了来自胰羧肽酶B的S1'亚位点。
Acta Crystallogr F Struct Biol Commun. 2018 Oct 1;74(Pt 10):638-643. doi: 10.1107/S2053230X18011962. Epub 2018 Sep 19.
8
Structural basis of the resistance of an insect carboxypeptidase to plant protease inhibitors.一种昆虫羧肽酶对植物蛋白酶抑制剂抗性的结构基础
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16602-7. doi: 10.1073/pnas.0505489102. Epub 2005 Oct 31.
9
Active site gate of M32 carboxypeptidases illuminated by crystal structure and molecular dynamics simulations.晶体结构和分子动力学模拟揭示 M32 羧肽酶的活性位点门控机制。
Biochim Biophys Acta Proteins Proteom. 2017 Nov;1865(11 Pt A):1406-1415. doi: 10.1016/j.bbapap.2017.07.023. Epub 2017 Aug 24.
10
Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily.禽羧肽酶D结构域II的晶体结构:调节性金属羧肽酶亚家族的一个原型
EMBO J. 1999 Nov 1;18(21):5817-26. doi: 10.1093/emboj/18.21.5817.

引用本文的文献

1
Structural and time-resolved mechanistic investigations of protein hydrolysis by the acidic proline-specific endoprotease from Aspergillus niger.黑曲霉中酸性脯氨酸特异性内肽酶对蛋白质水解的结构和时间分辨的机制研究。
Protein Sci. 2024 Jan;33(1):e4856. doi: 10.1002/pro.4856.
2
In Vitro and In Silico Investigation of BCI Anticancer Properties and Its Potential for Chemotherapy-Combined Treatments.脑机接口抗癌特性及其在化疗联合治疗中的潜力的体外和计算机模拟研究
Cancers (Basel). 2023 Sep 6;15(18):4442. doi: 10.3390/cancers15184442.
3
Post-Proline Cleaving Enzymes (PPCEs): Classification, Structure, Molecular Properties, and Applications.

本文引用的文献

1
Expression, purification and crystallization of human prolylcarboxypeptidase.人脯氨酰羧肽酶的表达、纯化及结晶
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Jun 1;66(Pt 6):702-5. doi: 10.1107/S1744309110014041. Epub 2010 May 27.
2
XDS.XDS.(这个词如果没有更多背景信息,很难准确翻译出更有意义的内容,直接保留原文是一种处理方式,或者音译为“克斯达斯”之类,但感觉都不太符合常规翻译场景,你可以补充更多关于这个词的信息以便我更准确翻译 )
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32. doi: 10.1107/S0907444909047337. Epub 2010 Jan 22.
3
MEROPS: the peptidase database.MEROPs:肽酶数据库。
脯氨酸裂解后酶(PPCEs):分类、结构、分子特性及应用
Plants (Basel). 2022 May 18;11(10):1330. doi: 10.3390/plants11101330.
4
Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates.人二肽基肽酶 III 与两种底物相互作用的分子动力学模拟研究。
Molecules. 2021 Oct 27;26(21):6492. doi: 10.3390/molecules26216492.
5
Structural basis for an exceptionally strong preference for asparagine residue at the S2 subsite of Stenotrophomonas maltophilia dipeptidyl peptidase 7.嗜麦芽窄食单胞菌二肽基肽酶7的S2亚位点对天冬酰胺残基具有极强偏好性的结构基础。
Sci Rep. 2021 Apr 12;11(1):7929. doi: 10.1038/s41598-021-86965-x.
6
Prolylcarboxypeptidase Mitigates Myocardial Ischemia/Reperfusion Injury by Stabilizing Mitophagy.脯氨酰羧肽酶通过稳定线粒体自噬减轻心肌缺血/再灌注损伤。
Front Cell Dev Biol. 2020 Oct 22;8:584933. doi: 10.3389/fcell.2020.584933. eCollection 2020.
7
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.6-取代己二烯基氨甲酰基密胺衍生物作为人尿激酶型纤溶酶原激活物的高效和选择性抑制剂在癌症中的应用。
J Med Chem. 2018 Sep 27;61(18):8299-8320. doi: 10.1021/acs.jmedchem.8b00838. Epub 2018 Sep 7.
8
Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.脯氨酰羧肽酶缺乏与血压升高、肾小球病变及心脏功能障碍相关,且与循环及心脏中的血管紧张素II改变无关。
J Mol Med (Berl). 2017 May;95(5):473-486. doi: 10.1007/s00109-017-1513-9. Epub 2017 Feb 3.
9
Cloning and expression of a novel prolyl endopeptidase from Aspergillus oryzae and its application in beer stabilization.米曲霉新型脯氨酰内肽酶的克隆、表达及其在啤酒稳定中的应用
J Ind Microbiol Biotechnol. 2015 Feb;42(2):263-72. doi: 10.1007/s10295-014-1571-8. Epub 2014 Dec 30.
10
Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).脯氨酰羧肽酶可独立激活血浆前激肽释放酶(弗莱彻因子)。
Curr Mol Med. 2014;14(9):1173-85. doi: 10.2174/1566524014666141015153519.
Nucleic Acids Res. 2010 Jan;38(Database issue):D227-33. doi: 10.1093/nar/gkp971. Epub 2009 Nov 5.
4
Prolylcarboxypeptidase regulates food intake by inactivating alpha-MSH in rodents.脯氨酰羧肽酶通过使啮齿动物体内的α-促黑素失活来调节食物摄入。
J Clin Invest. 2009 Aug;119(8):2291-303. doi: 10.1172/JCI37209. Epub 2009 Jul 20.
5
Prolylcarboxypeptidase: a cardioprotective enzyme.脯氨酰羧肽酶:一种具有心脏保护作用的酶。
Int J Biochem Cell Biol. 2009 Mar;41(3):477-81. doi: 10.1016/j.biocel.2008.02.022. Epub 2008 Feb 29.
6
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
7
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.MolProbity:蛋白质和核酸的全原子接触与结构验证
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83. doi: 10.1093/nar/gkm216. Epub 2007 Apr 22.
8
Automated structure solution with autoSHARP.使用autoSHARP进行自动结构解析。
Methods Mol Biol. 2007;364:215-30. doi: 10.1385/1-59745-266-1:215.
9
Engineering of a VPAC2 receptor peptide agonist to impart dipeptidyl peptidase IV stability and enhance in vivo glucose disposal.
J Med Chem. 2006 Dec 14;49(25):7545-8. doi: 10.1021/jm0609059.
10
Scaling and assessment of data quality.数据质量的评估与分级
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82. doi: 10.1107/S0907444905036693. Epub 2005 Dec 14.